Study finds that disease-modifying therapies for Alzheimer’s, lecanemab and donanemab, can extend independence in daily ...
CBS News New York takes a look at what's being done to help New Yorkers living with the disease, and those who are caring for them.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback